CareTrust REIT, Inc. (CTRE) — closed signal from March 12, 2026
Partial Published before the outcome was known, scored automatically when the window closed on June 10, 2026.
Predicted vs. what happened
What happened
Reached 75% of the predicted growth at its peak, without hitting the target.
The thesis — published March 12, 2026
CareTrust looks promising because its business is steady healthcare properties and recent company comments were positive. The stock may get extra buying when it joins the S&P MidCap index, but current price action hasn't fully turned higher. That means buying a small dip is smarter than jumping in now.
Primary drivers
- Joining the index can bring automatic buying from investment funds and extra demand
- Rent and fee income from healthcare buildings tends to be stable and defensive
- Management's recent comments were positive and support the outlook
- Buying on mild weakness reduces the chance of overpaying before momentum improves
How it played out
CTRE: target missed after a 9% peak gain
Lyra published CTRE on 2026-03-12 at $39.52, looking for 12% growth in a short-term window. The thesis pointed to index buying, steady rent and fee income from healthcare buildings, positive management comments, and waiting for mild weakness before momentum improved.
Inside the window, CTRE rose to $43.08 on 2026-05-14, a 9% peak gain. It stayed below the $44.26 target and never reached it. By 2026-06-10, it ended at $37.73. The thesis partially played out on the rise, but the target was missed and the close was below the publication price.
What happened during the window
On 2026-03-16, Barron's reported that CareTrust had raised its quarterly dividend to $0.39 per share, payable on 2026-04-15 to shareholders of record on 2026-03-31.
Prices are shown split- and dividend-adjusted, matching what public charts show today.
Read the next call before it closes.
This is one signal, scored after the fact. Today’s picks come with the same plain-language thesis — published before anyone knows the outcome.